세계의 림프 부종 치료 시장 - 규모, 점유율, 성장 분석 : 치료 유형별, 환부별, 연령층별, 투여 경로별, 유통 채널별, 최종 사용자별, 지역별, 산업별 예측(2025-2032년)
Lymphedema Treatment Market Size, Share, Growth Analysis, By Treatment Type, By Type, By Affected Area, By Age Group, By Route Of Administration, By Distribution Channel, By End User, By Region - Industry Forecast 2025-2032
상품코드:1623666
리서치사:SkyQuest Technology Consulting Pvt. Ltd.
발행일:2024년 12월
페이지 정보:영문 165 Pages
라이선스 & 가격 (부가세 별도)
한글목차
림프 부종 치료 시장 규모는 2023년에 8억 6,014만 달러로 평가되었고, 2024년 9억 4,185만 달러에서 2032년에는 19억 22만 달러로 성장해 예측 기간(2025-2032년) 중 CAGR는 9.5%로 나타날 전망입니다.
림프 부종 치료 시장은 유방암 이환율의 상승이나 암 생존자에 있어서의 림프 부종의 만연 등 여러 요인에 의해 큰 성장을 이루고 있습니다. 특히 유방암 치료를 받은 여성의 40%가 림프부종을 발병하고 있으며, 이는 치료 직후 나타나는 경우도 있고 수십년 후에 나타날 수도 있습니다. 이 질환은 주로 하지에 영향을 미치고 부인과 암 환자의 발병률이 높습니다. 효과적인 림프 부종 치료 솔루션에 대한 수요는 주요 시장 진출기업의 기술 발전과 제품 혁신에 의해 촉진되고 있습니다. 림프부종의 쇠약을 경험하는 환자, 특히 수술 후 환자가 많은 가운데, 최첨단 암 치료법의 지속적인 개발은 이 증상을 완화하고 시장 기회를 확대하는데 있어서 매우 중요합니다.
목차
소개
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차 데이터와 1차 데이터의 방법
시장 규모 예측
시장의 전제조건과 제한
주요 요약
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
억제요인과 과제
Porter's Five Forces 분석
주요 시장 인사이트
중요성공요인
경쟁도
주요 투자 기회
시장 생태계
시장의 매력 지수(2024년)
PESTEL 분석
거시경제지표
밸류체인 분석
가격 분석
사례 연구 분석
림프 부종 치료 시장 규모 : 치료 유형별 &CAGR(2025-2032년)
시장 개요
압박요법
수술
약 요법
레이저 치료
기타
림프부종 치료 시장 규모 : 유형별 &CAGR(2025-2032년)
시장 개요
이차성 림프 부종
원발성 림프 부종
림프 부종 치료 시장 규모 : 질환 부위별 &CAGR(2025-2032년)
시장 개요
하지
상지
성기
림프부종 치료 시장 규모 : 연령층별 &CAGR(2025-2032년)
시장 개요
성인
고령자
소아
림프부종 치료 시장 규모 : 투여경로별 &CAGR(2025-2032년)
시장 개요
경구
주사
국소
림프부종 치료 시장 규모 : 유통채널별 &CAGR(2025-2032년)
시장 개요
약국
직접 입찰
기타
림프 부종 치료 시장 규모 : 최종 사용자별 &CAGR(2025-2032년)
시장 개요
병원
전문 클리닉
외래수술센터(ASC)
기타
림프 부종 치료 시장 규모 &CAGR(2025-2032년)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카
기타 중동 및 아프리카
경쟁 정보
상위 5개사 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채용한 전략
시장의 최근 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 프로파일
제품 포트폴리오 분석
부문별 점유율 분석
수익의 전년대비 비교(2022-2024)
주요 기업 프로파일
Bio Compression Systems
Tactile Medical
Medi
Lympha Press
Sigvaris
BSN Medical
L&R USA Inc.
Devon Medical Products
3M Health Care
JOBST USA
Thuasne
Wright Therapy Products
BioHorizons IPH, Inc.
Haddenham Healthcare
ArjoHuntleigh
Paul Hartmann
Bioventus
Baxter International Inc.
CircAid Medical Products, Inc.
Essity Aktiebolag
결론과 권장사항
JHS
영문 목차
영문목차
Lymphedema Treatment Market size was valued at USD 860.14 Million in 2023 and is poised to grow from USD 941.85 Million in 2024 to USD 1900.22 Million by 2032, growing at a CAGR of 9.5% during the forecast period (2025-2032).
The lymphedema treatment market is experiencing significant growth, driven by several factors including the rising incidence of breast cancer and the prevalence of lymphedema among cancer survivors. Notably, 40% of women undergoing breast cancer treatment develop lymphedema, which can manifest soon after treatment or even decades later. The disorder primarily affects the lower extremities and has higher occurrences among gynecologic cancer patients. The demand for effective lymphedema treatment solutions is also fueled by advancements in technology and product innovation from major market players. With a substantial patient population experiencing lymphedema's debilitating effects, particularly post-surgery, ongoing development of cutting-edge cancer therapies is critical to mitigating this condition and expanding market opportunities.
Top-down and bottom-up approaches were used to estimate and validate the size of the Lymphedema Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Lymphedema Treatment Market Segmental Analysis
Global Lymphedema Treatment Market is segmented by treatment type, type, affected area, age group, route of administration, distribution channel, end user and region. Based on treatment type, the market is segmented intoCompression Therapy, surgery, drug therapy, laser therapy and others. Based on type, the market is segmented into secondary lymphedema and primary lymphedema. Based on affected area, the market is segmented into lower extremity, upper extremity and genitalia. Based on age group, the market is segmented into adult, geriatric and pediatric. Based on route of administration, the market is segmented into oral, injectable and topical. Based on distribution channel, the market is segmented into pharmacy stores, direct tender and others. Based on end user, the market is segmented into hospital, speciality clinics, ambulatory surgical centers and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Lymphedema Treatment Market
The lymphedema treatment market is expected to grow significantly due to the rising incidence of lymphedema and breast cancer. An increase in cancer cases presents vast opportunities for market expansion. Coupled with surging health expenditures and heightened investments in drug discovery and development, demand for healthcare facilities is on the rise. Furthermore, the anticipated emergence of innovative lymphedema treatment options is likely to drive market growth during the forecast period. Technological advancements in treatment methodologies will also contribute to this upward trend. Additionally, government initiatives and favorable reimbursement policies are set to support the market's expansion.
Restraints in the Lymphedema Treatment Market
The Lymphedema Treatment market faces notable restraints that may hinder its growth. Despite technological advancements in the field, there remains no definitive cure for lymphedema, which poses a significant challenge to market development. Furthermore, the considerable expenses associated with various procedures and treatment options are anticipated to deter potential patients and healthcare providers, ultimately affecting overall market expansion. The combination of the lack of a permanent solution and the financial burden of managing lymphedema underscores the need for continued research and innovation to address these limitations and improve patient access to effective treatments.
Market Trends of the Lymphedema Treatment Market
The lymphedema treatment market is poised for significant growth, driven by an increasing prevalence of the condition and expanding awareness among healthcare providers and patients. Innovative therapies and advanced technologies are emerging at a rapid pace, enhancing treatment efficacy and patient safety. Rising healthcare expenditures globally are further propelling market expansion, alongside ongoing advancements in healthcare innovation that focus on personalized treatment options. Additionally, pharmaceutical companies are introducing cutting-edge medical devices, which are not only improving treatment outcomes but also stimulating market dynamics on a global scale, thereby positioning the lymphedema treatment market for sustained growth in the coming years.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Study Analysis
Global Lymphedema Treatment Market Size by Treatment Type & CAGR (2025-2032)
Market Overview
Compression Therapy
Surgery
Drug Therapy
Laser Therapy
Others
Global Lymphedema Treatment Market Size by Type & CAGR (2025-2032)
Market Overview
Secondary Lymphedema
Primary Lymphedema
Global Lymphedema Treatment Market Size by Affected Area & CAGR (2025-2032)
Market Overview
Lower Extremity
Upper Extremity
Genitalia
Global Lymphedema Treatment Market Size by Age Group & CAGR (2025-2032)
Market Overview
Adult
Geriatric
Pediatric
Global Lymphedema Treatment Market Size by Route Of Administration & CAGR (2025-2032)
Market Overview
Oral
Injectable
Topical
Global Lymphedema Treatment Market Size by Distribution Channel & CAGR (2025-2032)
Market Overview
Pharmacy Stores
Direct Tender
Others
Global Lymphedema Treatment Market Size by End User & CAGR (2025-2032)
Market Overview
Hospital
Speciality Clinics
Ambulatory Surgical Centers
Others
Global Lymphedema Treatment Market Size & CAGR (2025-2032)
North America (Treatment Type, Type, Affected Area, Age Group, Route Of Administration, Distribution Channel, End User)
US
Canada
Europe (Treatment Type, Type, Affected Area, Age Group, Route Of Administration, Distribution Channel, End User)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Treatment Type, Type, Affected Area, Age Group, Route Of Administration, Distribution Channel, End User)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Treatment Type, Type, Affected Area, Age Group, Route Of Administration, Distribution Channel, End User)
Brazil
Rest of Latin America
Middle East & Africa (Treatment Type, Type, Affected Area, Age Group, Route Of Administration, Distribution Channel, End User)
